Navigation Links
TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment

LOD, Israel--(BUSINESS WIRE)--Jul 9, 2007 - TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today promising results of its phase I clinical trials demonstrating the safety and pharmacokinetic profile of its ViaDerm-hPTH (1-34) product for the treatment of osteoporosis.

A seven day, repeated dose application, parallel group study was conducted on 48 healthy, elderly, post-menopausal women. The study was designed to evaluate the safety and tolerability of ascending multiple doses of hPTH (1-34) patches and to compare the pharmacokinetic profiles of the transdermally delivered doses of hPTH (1-34) with that of FORTEO(R) administered subcutaneously.

Transdermal hPTH (1-34) was delivered using TransPharma's fully integrated product, which is comprised of a proprietary pocket-sized device and 1 cm(2) dry hPTH (1-34) patch with demonstrated room-temperature stability.

Once-daily transdermal delivery of all doses tested in this trial demonstrated a safety profile similar to the one observed in the FORTEO(R) subcutaneous injection. All safety parameters (including calcium and phosphorous) of the different transdermal doses were within the normal range. Furthermore, all ViaDerm-hPTH (1-34) doses were very well tolerated by participants.

Pharmacokinetic profiles of hPTH (1-34) in the first and seventh day were similar, showing no accumulation of hPTH (1-34) levels and no deterioration in hPTH (1-34) systemic levels. These findings demonstrate the ViaDerm-hPTH (1-34) product's ability to provide reproducible drug levels resulting in excellent inter- and intra-participant variability.

Transdermally delivered hPTH (1-34) of all doses showed desirable peak profiles with relative bioavailability of approximately 40%. This bioavailability is amo
'"/>




Page: 1 2 3

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
7. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
8. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
9. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
10. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
11. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
Post Your Comments:
(Date:10/30/2014)... 2014 The global market for human ... introduction of new vaccines. These new products and ... Market. The Kalorama information report examines the global ... developmental vaccines for diseases that are already vaccine-preventable. ... entire communities from diseases spread by person-to-person transmission. ...
(Date:10/27/2014)... , Oct. 27, 2014  RenovoRx, a leading developer ... and delivery of fluids to selected sites in the ... Directors has appointed Shaun Bagai as Chief ... RenovoRx Board of Directors. Bagai brings more than 15 ... Bagai joined RenovoRx in June 2014 and in ...
(Date:10/27/2014)... , Oct. 27, 2014  In the last few weeks, Ebola ... Africa to a worldwide crisis when a traveler ... virus and died, and two nurses were infected. While ... happen, the use of modern technology, such as electronic health records ... This week, InformationWeek Healthcare Editor Alison Diana ...
Breaking Medicine Technology:Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments 2Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments 3RenovoRx Board Names Shaun R. Bagai as CEO 2EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3
... SAN DIEGO, Jan. 17, 2012  Janssen Research & ... San Diego, a 30,000-square-foot life science innovation center, ... Center.  The innovation center provides a capital efficient, ... technologies and research platforms to advance medical care. ...
... Jan. 17, 2012   ULURU Inc. (NYSE AMEX: ... Melmed Holdings AG for the marketing of Altrazeal® ... Africa has been finalized. Under the terms of ... marketing of Altrazeal® to Melmed Holdings AG, who are establishing ...
Cached Medicine Technology:Janssen Research & Development, LLC Opens JANSSEN LABS at San Diego 2Janssen Research & Development, LLC Opens JANSSEN LABS at San Diego 3Janssen Research & Development, LLC Opens JANSSEN LABS at San Diego 4ULURU Inc. Completes Altrazeal® License Agreement for Europe 2ULURU Inc. Completes Altrazeal® License Agreement for Europe 3
(Date:10/30/2014)... by NIH grantees predicts that women must take the ... vaginal sex, whereas just two doses per week can ... finding helps explain why two large clinical trials testing ... show efficacy. Participants in the VOICE and ... antiretroviral) for HIV prevention were counseled to take one ...
(Date:10/30/2014)... Pompano Beach, Florida (PRWEB) October 30, 2014 ... surprise Halloween visit to Pompano Beach firefighters, showing that ... your community. , Timothy met firefighters Tracey and ... sponsored by Galuppi’s Restaurant and the Pompano Beach Chamber ... and outside the fire truck, letting Timothy wear his ...
(Date:10/30/2014)... NC (PRWEB) October 30, 2014 Don ... commercial, and health insurance plans for North Carolina residents, ... satellite office in Burlington’s Holly Hill Mall. The new ... with agents already helping customers through all facets of ... purchase. , Allred Insurance spokesman Scott Allred couldn’t be ...
(Date:10/30/2014)... 2014 Five months after their expansion, ... LLC announces new branding and a website to accompany ... After David Mepham’s promotion to name partner earlier this ... to include Mepham’s name and better reflect their combined ... firm, the decision to implement new branding reflects Hodgkinson ...
(Date:10/30/2014)... 30, 2014 Paramount Rx, a full-service ... increasing efforts to help people save money through its ... increase for prescription drugs in the new health care ... resources to bridge the relationship between consumers, businesses and ... biggest challenges people face today with medical costs is ...
Breaking Medicine News(10 mins):Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Allred Insurance Satellite Office Grand Opening 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3
... Discussion focuses on innovative programs, partnerships, and ... intergenerational mentoring in the workplace, WOONSOCKET, ... developing innovative workforce programs to recruit and retain,employees, was ... Aging,in America Conference in Washington, D.C. for a discussion ...
... Cardiology ... - FDA appeal progressing, TORONTO, March 28 /PRNewswire-FirstCall/ ... audited financial results,for the year ended December 31, 2007., "During ... and CEO. We made tremendous progress on,several fronts, including a License, ...
... The Pennsylvania,Health Care Cost Containment Council (PHC4) announced ... stepping down as head of the,innovative health care agency. ... his last day of employment has not yet been ... became Executive Director in,1998., "Marc has been a ...
... is Professor Patrick Tam from the Childrens Medical Research Institute, ... the Australian Academy of Science. , Peter Doherty, Ian Frazer ... have been honoured by election to the academy. Professor Tam ... , Professor Tam and his team have recently completed a ...
... NEW YORK, March 28 /Xinhua-PRNewswire-FirstCall/ -- China ... "Company") a leading,provider in the nutraceutical industry ... organic nutritional food products,supplements, and personal care ... in the final stages of the acquisition ...
... WELLINGTON, Fla., March 28 The Quantum ... announced today that,the Board of Directors and Noel ... have reached an agreement to amend his existing,employment ... of employment,with the Company. The terms of the ...
Cached Medicine News:Health News:CVS Caremark Presents at NCOA-ASA Conference on Company's Commitment to Recruiting and Retaining Mature Workers 2Health News:CVS Caremark Presents at NCOA-ASA Conference on Company's Commitment to Recruiting and Retaining Mature Workers 3Health News:PreMD Reports Fiscal 2007 Results 2Health News:PreMD Reports Fiscal 2007 Results 3Health News:PreMD Reports Fiscal 2007 Results 4Health News:PreMD Reports Fiscal 2007 Results 5Health News:PreMD Reports Fiscal 2007 Results 6Health News:PreMD Reports Fiscal 2007 Results 7Health News:PreMD Reports Fiscal 2007 Results 8Health News:PreMD Reports Fiscal 2007 Results 9Health News:PreMD Reports Fiscal 2007 Results 10Health News:PreMD Reports Fiscal 2007 Results 11Health News:PreMD Reports Fiscal 2007 Results 12Health News:National recognition for top scientist 2Health News:China Yingxia International Announces Soybean Milk Production Lines Acquisition 2Health News:The Quantum Group Extends CEO's Employment Agreement 2Health News:The Quantum Group Extends CEO's Employment Agreement 3
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Cottle Tenaculum Skin Hook. 5 1/2" small, shallow curve....
Goldman single hook....
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl...
Medicine Products: